Trial record 1 of 1 for:    nct01094691
Previous Study | Return to List | Next Study

Haufen Diagnostic Biomarkers of BK Renal Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01094691
Recruitment Status : Enrolling by invitation
First Posted : March 29, 2010
Last Update Posted : May 8, 2018
Astellas Pharma US, Inc.
Information provided by (Responsible Party):
Volker Nickeleit, MD, University of North Carolina, Chapel Hill

No Study Results Posted on for this Study
  Recruitment Status : Enrolling by invitation
  Estimated Primary Completion Date : July 2019
  Estimated Study Completion Date : December 2019